Resource Library

biomarker discovery services partner

NULISAqpcr™ AD 5-plex Assay for Alzheimer’s Biomarkers

Enabling absolute quantitation of APOE4, BD-pTau217, Aβ42, GFAP, and NfL in a single multiplexed assay.

Biomarker Services that Unlock Actionable Biology & Evidence

See how we decipher the heterogeneity in disease biology and patient response by integrating multiple layers of molecular data.

Mapping Human Metabolic Diversity with Foundation Models: A DynamiQ Approach

Uncovering meaningful physiological differences among patients who appear similar by diagnosis or lab values.

Proving Target Relevancy: A Fast Path to Functional Biology with FFPE Proteomics

Bridging the gap between genomic target discovery & functional target validation that provides proof of mechanism.

What Discovery Metabolomics Reveals About Human Biology

Novel biology is the key to discovery, and metabolomics enables scalable measure of varied functional metabolic states in humans.

Accelerating Biomarker Discovery with AI-Enhanced Omics

On closing the gap between molecular measurement & clinical meaning, rapidly extracting actionable biological signals.

The Omics Brief | Next-Gen FFPE Proteomics: Turning yesterday’s tissue into tomorrow’s breakthroughs

Discovering novel functional markers that capture tumor biology, TME interactions, and drug response/resistance in archived tissue.

Mass Spectrometry-Based FFPE Proteomics as a Transformational Platform for Modern Oncology R&D

Going beyond IHC to, for the first time, directly quantify the functional protein landscape of tumors in FFPE samples.

Inside Sapient’s Multi-Omics Revolution: A Deep Dive with Founder Mo Jain

PharmaShots delves into Sapient’s mission to transform multi-omics research through innovation & world-class partnerships.

FFPE Multi-Omics for Precision Oncology Platforms

Extending molecular insights beyond DNA and RNA to realize new value in existing FFPE tissue biobanks.

The Bio Report: “Rewriting Drug Discovery with an AI-Multi-Omics Approach”

A look at how AI-driven, multi-omics platforms are advancing the discovery and development of precision medicines.

FFPE Multi-Omics for Clinical Oncology

Unlocking functional biology, new biomarker insights, and responder profiles from archived trial samples.